What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Receptor
The scientist’s investigation covers issues in Adenosine receptor, Adenosine, Receptor, Internal medicine and Endocrinology.
His Adenosine receptor study frequently intersects with other fields, such as Molecular biology.
His Adenosine research incorporates themes from Mechanism of action, Agonist, Immunology, Cell biology and Heart rate.
His work in Agonist tackles topics such as Enzyme inhibitor which are related to areas like Stereochemistry and Protein kinase A.
His Receptor research integrates issues from Signal transduction, Pharmacology and Kidney metabolism.
In his research on the topic of Adenosine A2B receptor, Adenosine A3 Receptor Agonists, Xanthine and Chinese hamster ovary cell is strongly related with Adenosine A3 Receptor Antagonists.
His most cited work include:
- International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors (2203 citations)
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression (1648 citations)
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update (881 citations)
What are the main themes of his work throughout his whole career to date?
Adenosine receptor, Adenosine, Receptor, Internal medicine and Endocrinology are his primary areas of study.
His research integrates issues of Stereochemistry and Pharmacology in his study of Adenosine receptor.
His studies in Adenosine integrate themes in fields like Adenosine A1 receptor, Immunology, Ischemia, Cell biology and Adenosine A2A receptor.
His studies deal with areas such as Molecular biology and Xanthine as well as Receptor.
His Agonist research incorporates elements of Reperfusion injury and Anesthesia.
His work deals with themes such as Adenosine A2B receptor and Purinergic signalling, which intersect with Adenosine A3 receptor.
He most often published in these fields:
- Adenosine receptor (49.32%)
- Adenosine (47.15%)
- Receptor (35.50%)
What were the highlights of his more recent work (between 2010-2021)?
- Adenosine (47.15%)
- Immunology (16.26%)
- Receptor (35.50%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Adenosine, Immunology, Receptor, Internal medicine and Cell biology.
His Adenosine research includes elements of Agonist, Adenosine A3 receptor, Adenosine A2B receptor, Adenosine receptor and Immune system.
He combines subjects such as Neuroscience and Inosine with his study of Adenosine receptor.
His Immunology study combines topics from a wide range of disciplines, such as Reperfusion injury and Pharmacology.
His Receptor study deals with the bigger picture of Biochemistry.
Joel Linden interconnects Endocrinology and Type 2 diabetes in the investigation of issues within Internal medicine.
Between 2010 and 2021, his most popular works were:
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update (881 citations)
- Purinergic regulation of the immune system (364 citations)
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors (142 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Immune system
His primary areas of investigation include Adenosine, Cell biology, Receptor, Natural killer T cell and Purinergic signalling.
Joel Linden has included themes like Adenosine A2B receptor, Pharmacology and Pneumonia in his Adenosine study.
His work carried out in the field of Cell biology brings together such families of science as T cell and Cell.
Joel Linden specializes in Receptor, namely Adenosine receptor.
The concepts of his Purinergic signalling study are interwoven with issues in Adenosine A1 receptor, Adenosine A3 receptor, Signal transduction and Paracrine signalling.
Joel Linden focuses mostly in the field of Adenosine A1 receptor, narrowing it down to topics relating to Motility and, in certain cases, Endocrinology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
